Global Cell And Gene Therapy Clinical Trial Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 85

Published Date: 13 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The next generation of cell and gene therapies holds a significant promise for patients as an alternative treatment option or personalized medicine. Besides, the success rate of these products is also higher as compared to those for small-molecule products. This is due to the fact that CGT tends to target precise disease drivers rather than the broad targets for small-molecule therapy.

According to our (Global Info Research) latest study, the global Cell And Gene Therapy Clinical Trial market size was valued at USD 9 million in 2022 and is forecast to a readjusted size of USD 37 million by 2029 with a CAGR of 21.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Cell And Gene Therapy Clinical Trial market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Cell And Gene Therapy Clinical Trial market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell And Gene Therapy Clinical Trial market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell And Gene Therapy Clinical Trial market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cell And Gene Therapy Clinical Trial market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell And Gene Therapy Clinical Trial
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell And Gene Therapy Clinical Trial market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IQVIA, ICON Plc, Covance, Charles River Laboratory and PAREXEL International Corporation. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Cell And Gene Therapy Clinical Trial market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Phase I
    Phase II
    Phase III
    Phase IV

Market segment by Application
    Oncology
    Cardiology
    CNS
    Musculoskeletal
    Infectious Diseases
    Dermatology
    Endocrine, Metabolic, Genetic
    Immunology & Inflammation
    Ophthalmology
    Others(Gastroenterology, Hematology,etc.)

Market segment by players, this report covers
    IQVIA
    ICON Plc
    Covance
    Charles River Laboratory
    PAREXEL International Corporation

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell And Gene Therapy Clinical Trial product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell And Gene Therapy Clinical Trial, with revenue, gross margin and global market share of Cell And Gene Therapy Clinical Trial from 2018 to 2023.
Chapter 3, the Cell And Gene Therapy Clinical Trial competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell And Gene Therapy Clinical Trial market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell And Gene Therapy Clinical Trial.
Chapter 13, to describe Cell And Gene Therapy Clinical Trial research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Cell And Gene Therapy Clinical Trial
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Cell And Gene Therapy Clinical Trial by Type
        1.3.1 Overview: Global Cell And Gene Therapy Clinical Trial Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Type in 2022
        1.3.3 Phase I
        1.3.4 Phase II
        1.3.5 Phase III
        1.3.6 Phase IV
    1.4 Global Cell And Gene Therapy Clinical Trial Market by Application
        1.4.1 Overview: Global Cell And Gene Therapy Clinical Trial Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Oncology
        1.4.3 Cardiology
        1.4.4 CNS
        1.4.5 Musculoskeletal
        1.4.6 Infectious Diseases
        1.4.7 Dermatology
        1.4.8 Endocrine, Metabolic, Genetic
        1.4.9 Immunology & Inflammation
        1.4.10 Ophthalmology
        1.4.11 Others(Gastroenterology, Hematology,etc.)
    1.5 Global Cell And Gene Therapy Clinical Trial Market Size & Forecast
    1.6 Global Cell And Gene Therapy Clinical Trial Market Size and Forecast by Region
        1.6.1 Global Cell And Gene Therapy Clinical Trial Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Cell And Gene Therapy Clinical Trial Market Size by Region, (2018-2029)
        1.6.3 North America Cell And Gene Therapy Clinical Trial Market Size and Prospect (2018-2029)
        1.6.4 Europe Cell And Gene Therapy Clinical Trial Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Cell And Gene Therapy Clinical Trial Market Size and Prospect (2018-2029)
        1.6.6 South America Cell And Gene Therapy Clinical Trial Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Cell And Gene Therapy Clinical Trial Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 IQVIA
        2.1.1 IQVIA Details
        2.1.2 IQVIA Major Business
        2.1.3 IQVIA Cell And Gene Therapy Clinical Trial Product and Solutions
        2.1.4 IQVIA Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 IQVIA Recent Developments and Future Plans
    2.2 ICON Plc
        2.2.1 ICON Plc Details
        2.2.2 ICON Plc Major Business
        2.2.3 ICON Plc Cell And Gene Therapy Clinical Trial Product and Solutions
        2.2.4 ICON Plc Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 ICON Plc Recent Developments and Future Plans
    2.3 Covance
        2.3.1 Covance Details
        2.3.2 Covance Major Business
        2.3.3 Covance Cell And Gene Therapy Clinical Trial Product and Solutions
        2.3.4 Covance Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Covance Recent Developments and Future Plans
    2.4 Charles River Laboratory
        2.4.1 Charles River Laboratory Details
        2.4.2 Charles River Laboratory Major Business
        2.4.3 Charles River Laboratory Cell And Gene Therapy Clinical Trial Product and Solutions
        2.4.4 Charles River Laboratory Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Charles River Laboratory Recent Developments and Future Plans
    2.5 PAREXEL International Corporation
        2.5.1 PAREXEL International Corporation Details
        2.5.2 PAREXEL International Corporation Major Business
        2.5.3 PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Product and Solutions
        2.5.4 PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 PAREXEL International Corporation Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cell And Gene Therapy Clinical Trial Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Cell And Gene Therapy Clinical Trial by Company Revenue
        3.2.2 Top 3 Cell And Gene Therapy Clinical Trial Players Market Share in 2022
        3.2.3 Top 6 Cell And Gene Therapy Clinical Trial Players Market Share in 2022
    3.3 Cell And Gene Therapy Clinical Trial Market: Overall Company Footprint Analysis
        3.3.1 Cell And Gene Therapy Clinical Trial Market: Region Footprint
        3.3.2 Cell And Gene Therapy Clinical Trial Market: Company Product Type Footprint
        3.3.3 Cell And Gene Therapy Clinical Trial Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Cell And Gene Therapy Clinical Trial Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Cell And Gene Therapy Clinical Trial Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Application (2018-2023)
    5.2 Global Cell And Gene Therapy Clinical Trial Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Cell And Gene Therapy Clinical Trial Consumption Value by Type (2018-2029)
    6.2 North America Cell And Gene Therapy Clinical Trial Consumption Value by Application (2018-2029)
    6.3 North America Cell And Gene Therapy Clinical Trial Market Size by Country
        6.3.1 North America Cell And Gene Therapy Clinical Trial Consumption Value by Country (2018-2029)
        6.3.2 United States Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        6.3.3 Canada Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        6.3.4 Mexico Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Cell And Gene Therapy Clinical Trial Consumption Value by Type (2018-2029)
    7.2 Europe Cell And Gene Therapy Clinical Trial Consumption Value by Application (2018-2029)
    7.3 Europe Cell And Gene Therapy Clinical Trial Market Size by Country
        7.3.1 Europe Cell And Gene Therapy Clinical Trial Consumption Value by Country (2018-2029)
        7.3.2 Germany Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        7.3.3 France Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        7.3.5 Russia Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        7.3.6 Italy Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Cell And Gene Therapy Clinical Trial Market Size by Region
        8.3.1 Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value by Region (2018-2029)
        8.3.2 China Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        8.3.3 Japan Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        8.3.4 South Korea Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        8.3.5 India Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        8.3.7 Australia Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Cell And Gene Therapy Clinical Trial Consumption Value by Type (2018-2029)
    9.2 South America Cell And Gene Therapy Clinical Trial Consumption Value by Application (2018-2029)
    9.3 South America Cell And Gene Therapy Clinical Trial Market Size by Country
        9.3.1 South America Cell And Gene Therapy Clinical Trial Consumption Value by Country (2018-2029)
        9.3.2 Brazil Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        9.3.3 Argentina Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Cell And Gene Therapy Clinical Trial Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Cell And Gene Therapy Clinical Trial Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Cell And Gene Therapy Clinical Trial Market Size by Country
        10.3.1 Middle East & Africa Cell And Gene Therapy Clinical Trial Consumption Value by Country (2018-2029)
        10.3.2 Turkey Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)
        10.3.4 UAE Cell And Gene Therapy Clinical Trial Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Cell And Gene Therapy Clinical Trial Market Drivers
    11.2 Cell And Gene Therapy Clinical Trial Market Restraints
    11.3 Cell And Gene Therapy Clinical Trial Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Cell And Gene Therapy Clinical Trial Industry Chain
    12.2 Cell And Gene Therapy Clinical Trial Upstream Analysis
    12.3 Cell And Gene Therapy Clinical Trial Midstream Analysis
    12.4 Cell And Gene Therapy Clinical Trial Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Cell And Gene Therapy Clinical Trial Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Cell And Gene Therapy Clinical Trial Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Cell And Gene Therapy Clinical Trial Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Cell And Gene Therapy Clinical Trial Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. IQVIA Company Information, Head Office, and Major Competitors
    Table 6. IQVIA Major Business
    Table 7. IQVIA Cell And Gene Therapy Clinical Trial Product and Solutions
    Table 8. IQVIA Cell And Gene Therapy Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. IQVIA Recent Developments and Future Plans
    Table 10. ICON Plc Company Information, Head Office, and Major Competitors
    Table 11. ICON Plc Major Business
    Table 12. ICON Plc Cell And Gene Therapy Clinical Trial Product and Solutions
    Table 13. ICON Plc Cell And Gene Therapy Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. ICON Plc Recent Developments and Future Plans
    Table 15. Covance Company Information, Head Office, and Major Competitors
    Table 16. Covance Major Business
    Table 17. Covance Cell And Gene Therapy Clinical Trial Product and Solutions
    Table 18. Covance Cell And Gene Therapy Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Covance Recent Developments and Future Plans
    Table 20. Charles River Laboratory Company Information, Head Office, and Major Competitors
    Table 21. Charles River Laboratory Major Business
    Table 22. Charles River Laboratory Cell And Gene Therapy Clinical Trial Product and Solutions
    Table 23. Charles River Laboratory Cell And Gene Therapy Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Charles River Laboratory Recent Developments and Future Plans
    Table 25. PAREXEL International Corporation Company Information, Head Office, and Major Competitors
    Table 26. PAREXEL International Corporation Major Business
    Table 27. PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Product and Solutions
    Table 28. PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. PAREXEL International Corporation Recent Developments and Future Plans
    Table 30. Global Cell And Gene Therapy Clinical Trial Revenue (USD Million) by Players (2018-2023)
    Table 31. Global Cell And Gene Therapy Clinical Trial Revenue Share by Players (2018-2023)
    Table 32. Breakdown of Cell And Gene Therapy Clinical Trial by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 33. Market Position of Players in Cell And Gene Therapy Clinical Trial, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 34. Head Office of Key Cell And Gene Therapy Clinical Trial Players
    Table 35. Cell And Gene Therapy Clinical Trial Market: Company Product Type Footprint
    Table 36. Cell And Gene Therapy Clinical Trial Market: Company Product Application Footprint
    Table 37. Cell And Gene Therapy Clinical Trial New Market Entrants and Barriers to Market Entry
    Table 38. Cell And Gene Therapy Clinical Trial Mergers, Acquisition, Agreements, and Collaborations
    Table 39. Global Cell And Gene Therapy Clinical Trial Consumption Value (USD Million) by Type (2018-2023)
    Table 40. Global Cell And Gene Therapy Clinical Trial Consumption Value Share by Type (2018-2023)
    Table 41. Global Cell And Gene Therapy Clinical Trial Consumption Value Forecast by Type (2024-2029)
    Table 42. Global Cell And Gene Therapy Clinical Trial Consumption Value by Application (2018-2023)
    Table 43. Global Cell And Gene Therapy Clinical Trial Consumption Value Forecast by Application (2024-2029)
    Table 44. North America Cell And Gene Therapy Clinical Trial Consumption Value by Type (2018-2023) & (USD Million)
    Table 45. North America Cell And Gene Therapy Clinical Trial Consumption Value by Type (2024-2029) & (USD Million)
    Table 46. North America Cell And Gene Therapy Clinical Trial Consumption Value by Application (2018-2023) & (USD Million)
    Table 47. North America Cell And Gene Therapy Clinical Trial Consumption Value by Application (2024-2029) & (USD Million)
    Table 48. North America Cell And Gene Therapy Clinical Trial Consumption Value by Country (2018-2023) & (USD Million)
    Table 49. North America Cell And Gene Therapy Clinical Trial Consumption Value by Country (2024-2029) & (USD Million)
    Table 50. Europe Cell And Gene Therapy Clinical Trial Consumption Value by Type (2018-2023) & (USD Million)
    Table 51. Europe Cell And Gene Therapy Clinical Trial Consumption Value by Type (2024-2029) & (USD Million)
    Table 52. Europe Cell And Gene Therapy Clinical Trial Consumption Value by Application (2018-2023) & (USD Million)
    Table 53. Europe Cell And Gene Therapy Clinical Trial Consumption Value by Application (2024-2029) & (USD Million)
    Table 54. Europe Cell And Gene Therapy Clinical Trial Consumption Value by Country (2018-2023) & (USD Million)
    Table 55. Europe Cell And Gene Therapy Clinical Trial Consumption Value by Country (2024-2029) & (USD Million)
    Table 56. Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value by Type (2018-2023) & (USD Million)
    Table 57. Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value by Type (2024-2029) & (USD Million)
    Table 58. Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value by Application (2018-2023) & (USD Million)
    Table 59. Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value by Application (2024-2029) & (USD Million)
    Table 60. Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value by Region (2018-2023) & (USD Million)
    Table 61. Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value by Region (2024-2029) & (USD Million)
    Table 62. South America Cell And Gene Therapy Clinical Trial Consumption Value by Type (2018-2023) & (USD Million)
    Table 63. South America Cell And Gene Therapy Clinical Trial Consumption Value by Type (2024-2029) & (USD Million)
    Table 64. South America Cell And Gene Therapy Clinical Trial Consumption Value by Application (2018-2023) & (USD Million)
    Table 65. South America Cell And Gene Therapy Clinical Trial Consumption Value by Application (2024-2029) & (USD Million)
    Table 66. South America Cell And Gene Therapy Clinical Trial Consumption Value by Country (2018-2023) & (USD Million)
    Table 67. South America Cell And Gene Therapy Clinical Trial Consumption Value by Country (2024-2029) & (USD Million)
    Table 68. Middle East & Africa Cell And Gene Therapy Clinical Trial Consumption Value by Type (2018-2023) & (USD Million)
    Table 69. Middle East & Africa Cell And Gene Therapy Clinical Trial Consumption Value by Type (2024-2029) & (USD Million)
    Table 70. Middle East & Africa Cell And Gene Therapy Clinical Trial Consumption Value by Application (2018-2023) & (USD Million)
    Table 71. Middle East & Africa Cell And Gene Therapy Clinical Trial Consumption Value by Application (2024-2029) & (USD Million)
    Table 72. Middle East & Africa Cell And Gene Therapy Clinical Trial Consumption Value by Country (2018-2023) & (USD Million)
    Table 73. Middle East & Africa Cell And Gene Therapy Clinical Trial Consumption Value by Country (2024-2029) & (USD Million)
    Table 74. Cell And Gene Therapy Clinical Trial Raw Material
    Table 75. Key Suppliers of Cell And Gene Therapy Clinical Trial Raw Materials
List of Figures
    Figure 1. Cell And Gene Therapy Clinical Trial Picture
    Figure 2. Global Cell And Gene Therapy Clinical Trial Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Type in 2022
    Figure 4. Phase I
    Figure 5. Phase II
    Figure 6. Phase III
    Figure 7. Phase IV
    Figure 8. Global Cell And Gene Therapy Clinical Trial Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Application in 2022
    Figure 10. Oncology Picture
    Figure 11. Cardiology Picture
    Figure 12. CNS Picture
    Figure 13. Musculoskeletal Picture
    Figure 14. Infectious Diseases Picture
    Figure 15. Dermatology Picture
    Figure 16. Endocrine, Metabolic, Genetic Picture
    Figure 17. Immunology & Inflammation Picture
    Figure 18. Ophthalmology Picture
    Figure 19. Global Cell And Gene Therapy Clinical Trial Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 20. Global Cell And Gene Therapy Clinical Trial Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 21. Global Market Cell And Gene Therapy Clinical Trial Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 22. Global Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Region (2018-2029)
    Figure 23. Global Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Region in 2022
    Figure 24. North America Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East and Africa Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Cell And Gene Therapy Clinical Trial Revenue Share by Players in 2022
    Figure 30. Cell And Gene Therapy Clinical Trial Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 31. Global Top 3 Players Cell And Gene Therapy Clinical Trial Market Share in 2022
    Figure 32. Global Top 6 Players Cell And Gene Therapy Clinical Trial Market Share in 2022
    Figure 33. Global Cell And Gene Therapy Clinical Trial Consumption Value Share by Type (2018-2023)
    Figure 34. Global Cell And Gene Therapy Clinical Trial Market Share Forecast by Type (2024-2029)
    Figure 35. Global Cell And Gene Therapy Clinical Trial Consumption Value Share by Application (2018-2023)
    Figure 36. Global Cell And Gene Therapy Clinical Trial Market Share Forecast by Application (2024-2029)
    Figure 37. North America Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Type (2018-2029)
    Figure 38. North America Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Application (2018-2029)
    Figure 39. North America Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Country (2018-2029)
    Figure 40. United States Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 41. Canada Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 42. Mexico Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 43. Europe Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Type (2018-2029)
    Figure 44. Europe Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Application (2018-2029)
    Figure 45. Europe Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 47. France Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 48. United Kingdom Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 49. Russia Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 50. Italy Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 55. Japan Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 56. South Korea Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 57. India Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 59. Australia Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 60. South America Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Type (2018-2029)
    Figure 61. South America Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Application (2018-2029)
    Figure 62. South America Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 64. Argentina Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 65. Middle East and Africa Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Type (2018-2029)
    Figure 66. Middle East and Africa Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Application (2018-2029)
    Figure 67. Middle East and Africa Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Country (2018-2029)
    Figure 68. Turkey Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 69. Saudi Arabia Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 70. UAE Cell And Gene Therapy Clinical Trial Consumption Value (2018-2029) & (USD Million)
    Figure 71. Cell And Gene Therapy Clinical Trial Market Drivers
    Figure 72. Cell And Gene Therapy Clinical Trial Market Restraints
    Figure 73. Cell And Gene Therapy Clinical Trial Market Trends
    Figure 74. Porters Five Forces Analysis
    Figure 75. Manufacturing Cost Structure Analysis of Cell And Gene Therapy Clinical Trial in 2022
    Figure 76. Manufacturing Process Analysis of Cell And Gene Therapy Clinical Trial
    Figure 77. Cell And Gene Therapy Clinical Trial Industrial Chain
    Figure 78. Methodology
    Figure 79. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

IQVIA
ICON Plc
Covance
Charles River Laboratory
PAREXEL International Corporation

Related Reports

Global Cell And Gene Therapy Clinical Trial Supply, Demand and Key Producers, 2023-2029

Global Cell And Gene Therapy Clinical Trial Supply, Demand and Key Producers, 2023-2029

date 13 Feb 2023

date Medical Devices & Consumables

The global Cell And Gene Therapy Clinical Trial market size is expected to reach $ 37 million by 2029, rising at a market growth of 21.3% CAGR during the forecast period (2023-2029).

Global Cell And Gene Therapy Clinical Trial Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cell And Gene Therapy Clinical Trial Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 07 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Cell And Gene Therapy Clinical Trial market size was valued at USD 9 million in 2023 and is forecast to a readjusted size of USD 37 million by 2030 with a CAGR of 21.3% during review period.

Global Cell And Gene Therapy Clinical Trial Supply, Demand and Key Producers, 2024-2030

Global Cell And Gene Therapy Clinical Trial Supply, Demand and Key Producers, 2024-2030

date 11 Feb 2024

date Medical Devices & Consumables

The global Cell And Gene Therapy Clinical Trial market size is expected to reach $ 37 million by 2030, rising at a market growth of 21.3% CAGR during the forecast period (2024-2030).

Product Tags

Cell And Gene Therapy Clinical Trial

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>